source
- GSK completes $10.6 billion acquisition of Nuvalent, the largest in its historyGSK announced it has completed a $10.6 billion purchase of Nuvalent, marking the biggest deal the company has ever undertaken. The transaction was disclosed on Tuesday and values Nuvalent at $124…
- Prometheus secures $12 billion to develop artificial general engineers as biotech deals surgePrometheus announced a $12 billion capital raise aimed at building what it calls “artificial general engineers,” a new class of AI tools for biopharma research and development. Nonprofit Blood Can…